| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,196 |
4,453 |
$334K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,229 |
2,129 |
$203K |
| 93000 |
|
935 |
926 |
$13K |
| 99401 |
|
668 |
640 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
331 |
306 |
$10K |
| 86328 |
|
264 |
262 |
$9K |
| 99441 |
|
203 |
189 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
211 |
211 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
374 |
359 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
75 |
74 |
$5K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
690 |
686 |
$4K |
| 90756 |
|
175 |
172 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
37 |
37 |
$3K |
| 90674 |
|
94 |
94 |
$3K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
25 |
24 |
$2K |
| 82607 |
|
215 |
215 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
281 |
281 |
$2K |
| 84481 |
|
288 |
288 |
$2K |
| 82728 |
|
193 |
193 |
$2K |
| 82746 |
|
203 |
203 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
342 |
342 |
$2K |
| 80076 |
|
337 |
337 |
$2K |
| 84439 |
|
275 |
275 |
$2K |
| 80061 |
Lipid panel |
304 |
304 |
$2K |
| 94760 |
|
4,180 |
3,556 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
169 |
169 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
338 |
338 |
$950.72 |
| 83550 |
|
192 |
192 |
$820.10 |
| 83540 |
|
192 |
192 |
$813.04 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
71 |
56 |
$789.71 |
| 0012A |
|
20 |
20 |
$770.37 |
| 0011A |
|
21 |
21 |
$755.36 |
| 83735 |
|
173 |
173 |
$732.63 |
| 99442 |
|
18 |
18 |
$678.39 |
| 90688 |
|
39 |
39 |
$654.25 |
| A4556 |
Electrodes, (e.g., apnea monitor), per pair |
811 |
803 |
$629.01 |
| 84100 |
|
140 |
140 |
$542.23 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
26 |
14 |
$317.21 |
| 81003 |
|
136 |
135 |
$220.04 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
31 |
31 |
$210.53 |
| 99072 |
|
523 |
451 |
$208.50 |
| 36415 |
Collection of venous blood by venipuncture |
501 |
489 |
$190.64 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
709 |
657 |
$77.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
70 |
55 |
$69.55 |
| 99606 |
|
80 |
71 |
$27.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
348 |
331 |
$1.75 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
260 |
235 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
177 |
162 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
203 |
200 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
158 |
152 |
$0.00 |
| 99000 |
|
50 |
50 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
12 |
12 |
$0.00 |
| 1036F |
|
27 |
24 |
$0.00 |
| 84480 |
|
13 |
13 |
$0.00 |